CAR-T cells: the Chinese experience

Changju Qu, Nana Ping, Qian Wu, Liqing Kang, Fan Xia, Lei Yu, Depei Wu, Zhengming Jin, Radiotherapy Priming Chimeric Antigen Receptor T Cell Therapy Is a Safe and Promising Approach in Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients with High Tumor Burden Blood. ,vol. 132, pp. 2961- 2961 ,(2018) , 10.1182/BLOOD-2018-99-113979

Sanfang Tu, Lan Deng, Rui Huang, Xuan Zhou, Jilong Yang, Weijun Zhou, Meifang Li, Chunyan Yue, Shaojie Wu, Zhenling Guo, Lung-Ji Chang, Yuhua Li, A Novel Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD123 to Treat Relapsed Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation Blood. ,vol. 132, pp. 4015- 4015 ,(2018) , 10.1182/BLOOD-2018-99-118526

Rongli Zhang, Yi He, Donglin Yang, Ying Wang, Sizhou Feng, Jianxiang Wang, Ming-Zhe Han, Donor-Derived Second Generation of CD19 CAR-T Cell Therapy for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogenic Stem Cell Transplantation Blood. ,vol. 132, pp. 2179- 2179 ,(2018) , 10.1182/BLOOD-2018-99-114950

Peihua Lu, Junfang Yang, Jianqiang Li, Xian Zhang, Fanyong LV, Xiaoling Guo, Qinglong Wang, Lin Wang, Dandan Chen, Xiaosu Zhou, Jinhai Ren, A Feasibility and Safety Study of CD19 and CD22 Chimeric Antigen Receptors-Modified T Cell Cocktail for Therapy of B Cell Acute Lymphoblastic Leukemia Blood. ,vol. 132, pp. 277- 277 ,(2018) , 10.1182/BLOOD-2018-99-114415

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal, Cancer statistics, 2019. CA: A Cancer Journal for Clinicians. ,vol. 69, pp. 7- 34 ,(2019) , 10.3322/CAAC.21551

Yongxian Hu, Jiasheng Wang, Yanlei Zhang, Guoqing Wei, Huijun Xu, Wenjun Wu, Jian Yu, Yi Luo, Jimin Shi, Shaohui Liu, Kangyan Wang, Zhenxing Guo, Alex HONGSHENG Chang, He Huang, Comparison of Chimeric Antigen Receptor T Cells from Allogenic or Autologous Sources in Patients with Acute Lymphoblastic Leukemia Blood. ,vol. 132, pp. 2691- 2691 ,(2018) , 10.1182/BLOOD-2018-99-117910

Lung-Ji Chang, Yuhua Li, Sanfang Tu, Xun Lai, Rui Huang, Shih-Ting Tsao, Yu-Chen Liu, Rui Zhang, Lan Deng, Xuan Zhou, Hongyu Zhang, Wenli Zhang, Yuchen Li, Phase I/II Trial of Multi-Target Chimeric Antigen Receptor Modified T Cells (4SCAR2.0) Against Relapsed or Refractory Lymphomas Blood. ,vol. 132, pp. 225- 225 ,(2018) , 10.1182/BLOOD-2018-99-114396

Tiantian Ma, Jing Shi, Huasheng Liu, Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma. Annals of Hematology. ,vol. 98, pp. 813- 822 ,(2019) , 10.1007/S00277-018-03592-9

Liang Huang, Na Wang, Yang Cao, Chunrui Li, Yi Xiao, Min Xiao, Xiaoxi Zhou, Gaoxiang Wang, Zhenya Hong, Miao Zhen, Weixu Meng, Bin Zhang, Yicheng Zhang, Guido Marcucci, Tongcun Zhang, Jianfeng Zhou, CAR22/19 Cocktail Therapy for Patients with Refractory/Relapsed B-Cell Malignancies Blood. ,vol. 132, pp. 1408- 1408 ,(2018) , 10.1182/BLOOD-2018-99-113714

Shuangyou Liu, Biping Deng, Yuehui Lin, Zhichao Yin, Jing Pan, Tong Wu, Zhiyong Gao, Yanzhi Song, Yongqiang Zhao, Chunrong Tong, Sequential CD19- and CD22-CART Cell Therapies for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation Blood. ,vol. 132, pp. 2126- 2126 ,(2018) , 10.1182/BLOOD-2018-99-111856